NCT00418730View on ClinicalTrials.gov

Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

April 30, 2008

Conditions
Androgenetic Alopecia
Interventions
DRUG

tetrapeptide aldehyde proteasome inhibitor (NEOSH101)

Study preparation (experimental, active comparator, placebo comparator) will be applied twice daily to the scalp for 112 days

Trial Locations (1)

20095

bioskin Institute for Dermatological Research and Development GmbH, Hamburg

All Listed Sponsors
lead

Neosil, Inc.

INDUSTRY

NCT00418730 - Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss | Biotech Hunter | Biotech Hunter